{"path":".obsidian/plugins/text-extractor/cache/de356e060a59b19c824baa4039e3125d.json","text":"Identification of differentially expressed genes S * In the discovery cohort, on average 16,190 (min/max: 6711/17790) i expressed genes were detected using RNA sequencing. Differentially 5 . il expression analysis identified 108 genes statistically differentially 5 i modulated (|log2FC| > 1, p < 0.01, p-adj < 0.01) between the two §, © - :‘ groups of patients (Fig. 2]:H genes were upregulated andi 2 . . downregulated in the unfavorable prognosis group compared to the = B S T favorable prognosis group. Magnitude of fold changes (log2 scale) was ol - e within -2.4 0 +3.5. 3 - PR k= & i 57 ¥ | e S et 4 A:‘(:] * Among the upregulated genes, 42 belonged to the olfactory signaling s e pathways and were not further considered. Among 62 remaining upregulated genes, 17 were pseudogenes, 10 uncharacterized noncoding RNA, 4 were involved in the immune response (e.g., IFNs) = and one was a miRNA (MIR548I11). Further 14 genes were cancer- -2 -1 0 1 2 3 related (e.g., CETN1). The remaining upregulated genes (n = 16), most good vs. poor prognosis (log2 FC) of which involved in key cellular processes (e.g., SNRNP48) have not yet been associated with cancer and/or cancer prognosis. Volcano plot of differentially expressed genes (DEGs) between two extreme cohorts of stage Il CRC patients. Red circles, 108 DEGs (log2FC| > 1, p < 0.01, p-adj < 0.01). . YC{INU Laboratory of Microbial Genomics","libVersion":"0.2.2","langs":"eng"}